Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Prosensa Therapeutics
ClinicalTrials.gov Identifier:
NCT01037309
First received: December 21, 2009
Last updated: December 19, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)